- Home
- ONDS vs HUMA Comparison
ONDS vs HUMA Comparison
Compare ONDS & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONDS
- HUMA
- Stock Information
- Founded
- ONDS 2014
- HUMA 2004
- Country
- ONDS United States
- HUMA United States
- Employees
- ONDS N/A
- HUMA N/A
- Industry
- ONDS Telecommunications Equipment
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- ONDS Telecommunications
- HUMA Health Care
- Exchange
- ONDS Nasdaq
- HUMA Nasdaq
- Market Cap
- ONDS 1.4B
- HUMA 250.2M
- IPO Year
- ONDS N/A
- HUMA N/A
- Fundamental
- Price
- ONDS $5.86
- HUMA $1.51
- Analyst Decision
- ONDS Strong Buy
- HUMA Strong Buy
- Analyst Count
- ONDS 3
- HUMA 8
- Target Price
- ONDS $4.67
- HUMA $10.88
- AVG Volume (30 Days)
- ONDS 49.3M
- HUMA 5.9M
- Earning Date
- ONDS 08-12-2025
- HUMA 08-11-2025
- Dividend Yield
- ONDS N/A
- HUMA N/A
- EPS Growth
- ONDS N/A
- HUMA N/A
- EPS
- ONDS N/A
- HUMA N/A
- Revenue
- ONDS $16,131,404.00
- HUMA $818,000.00
- Revenue This Year
- ONDS $246.94
- HUMA N/A
- Revenue Next Year
- ONDS $161.09
- HUMA $949.92
- P/E Ratio
- ONDS N/A
- HUMA N/A
- Revenue Growth
- ONDS 75.16
- HUMA N/A
- 52 Week Low
- ONDS $0.57
- HUMA $1.15
- 52 Week High
- ONDS $6.19
- HUMA $6.77
- Technical
- Relative Strength Index (RSI)
- ONDS 79.19
- HUMA 36.87
- Support Level
- ONDS $3.20
- HUMA $1.43
- Resistance Level
- ONDS $4.33
- HUMA $1.67
- Average True Range (ATR)
- ONDS 0.54
- HUMA 0.15
- MACD
- ONDS 0.17
- HUMA -0.01
- Stochastic Oscillator
- ONDS 89.02
- HUMA 23.32
About ONDS Ondas Holdings Inc.
Ondas Holdings Inc designs, develops, manufactures, sells, and supports FullMAX Software Defined Radio (SDR) technology in the United States, Israel, and India. The company operates in two business segments namely Ondas Networks and Ondas Autonomous Systems. The company generates maximum revenue from Ondas Autonomous Systems through the sales of the Optimus system and separately priced support, maintenance, and ancillary services related to the sale of the Optimus system.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.